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Background: Age-associated disability reduces quality of life in older populations and leads to wide-range implications
for social and health policy. The identification of diseases that contribute to the disability burden is crucial to
the development of prevention and intervention strategies to reduce disability. In this study, we assessed the
contribution of chronic diseases to the prevalence of disability in Belgium.
Methods: Data from 35,837 individuals aged 15 years or older who participated in the 1997, 2001, 2004, or
2008 Belgian Health Interview Surveys were used. Disability was defined as difficulties in doing at least one of
six activities of daily living (transfer in and out of bed, transfer in and out of chair, dressing, washing hands and
face, feeding, and going to the toilet) and/or mobility limitations (ability to walk without stopping less than 200 m).
Multiple additive regression models were fitted separately for men and women to estimate the age-specific background
disability rate (experienced by everyone, independent of the presence of specific diseases) and disease-specific disability
rates (disability rate in subjects who reported selected chronic diseases).
Results: Musculoskeletal, cardiovascular, and respiratory diseases were the main contributors to the disability burden in
Belgium. Musculoskeletal diseases were the most prevalent diseases in men and women in all age groups. Neurological
diseases and stroke were the most disabling diseases, i.e. caused the highest level of disability among the diseased
individuals, in all age groups for men and women, respectively. Back pain was the main cause of disability in men aged
15 to 64 years, while heart attack was the major contributor to the disability prevalence in men aged 65 or older. Likewise,
arthritis was the main cause of disability among women across all age groups. Depression was also an important
contributor in young subjects (15–54 years). Cancer was not an important contributor to the disability prevalence in
Belgium.
Conclusions: To reduce the burden of disability in Belgium, interventions should target musculoskeletal, cardiovascular
and respiratory diseases especially among elderly. Furthermore, attention should also be given to depression in young
individuals.
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Global population aging accompanied by an increased
longevity with disability has raised international concern,
particularly due to its social and economic costs for
health care systems [1]. The identification of diseases
with greatest potential to influence the health of popula-
tions can assist public health policies in the definition of
prevention and control strategies [2,3].
Although longitudinal studies are considered the gold
standard in the assessment of disability causes, their use
is often limited due to their high costs, which can result
in restricted sample sizes and lack of representativeness
of large populations [4]. Alternative methods have been
proposed to assess the impact of specific diseases in the
burden of disability using cross-sectional data [5-10].
The first methods were focused on the effect of elimin-
ation of specific diseases on mortality and disability
[5-9]. However, the results depend upon the order a
cause is removed, which can produce inconsistent re-
sults in the presence of comorbidity [11]. Also, these
methods often rely on a multiplicative model (logistic re-
gression) which does not yield additive contributions of
diseases [11]. To overcome this limitation, the use of the
average attributable fraction was proposed and recently
applied on the estimation of disability by cause in France
[12]. The main drawback of this approach is the use of
the odds ratio (OR) as a measure of the relative risk, es-
pecially for diseases with high prevalence, which is the
case of several chronic diseases [5]. When the OR is not
used, the method relies on the availability of relative
risks in the literature [5]. As an alternative, Nusselder
and Looman [10,13] proposed a method based on the
use of additive hazards models to attribute the total dis-
ability prevalence into cause-specific contributions of
diseases and background in the presence of comorbidity
[11]. In this approach, the background represents causes
of disability not included in the analysis.
To date, only six studies using data from Belgium [13],
The Netherlands [3,10,11], Germany [14] and China [15]
estimated the disability prevalence by cause using the at-
tribution method. In this study, the contribution of spe-
cific chronic diseases to the prevalence of disability in
Belgium using the attribution method [10] is presented.
Methods
Study participants
Individuals aged 15 years or older who participated in
the Belgian Health Interview Survey (HIS) of 1997, 2001,
2004 or 2008 were included in this study. The Belgian
HIS is a household survey based on a representative,
stratified (regions and provinces) and clustered (mun-
icipalities and households) sample of the Belgian pop-
ulation, including also elderly subjects admitted in
institutions. Each survey included approximately 10,000individuals. The response rate was 59% in 1997, 61% in
2001, 61% in 2004, and 55% in 2008. Sampling weights
were used to take into account the complex sample de-
sign. Approximately 200 interviewers were necessary for
the data collection in each HIS. All interviewers followed
a training to ensure standardisation of data collection
and field work procedures. The data collection included
a face-to-face interview and a self-administered ques-
tionnaire. More details about the surveys methodology
can be found in previous publications [16,17]. The
Belgian HIS data is available upon request (https://his.
wiv-isp.be/SitePages/Acces_microdata.aspx) and approval
of the Belgian Commission of Privacy Protection. In-
formed consent was obtained from all survey partici-
pants. The data collection was carried out by Statistics
Belgium and the surveys were exempted by law from
requiring ethical approval.
The disability and disease/conditions questions were
included in the face-to-face questionnaire in the four
HIS. Since the disability questions were restricted to the
population of 15 years or older, the analysis was also
limited to this subsample. The data of the four HIS were
pooled, resulting in 39,587 subjects. Due to lack of dis-
ease (n = 1,975) or disability information (n = 1,891),
3,750 (9%) individuals were excluded from the analysis,
resulting in a sample of 35,837 subjects (7,928 in the
1997 HIS; 9,183 in the 2001 HIS; 9,996 in the 2004 HIS;
and 8,730 in the 2008 HIS). More detailed information
on the study participants is presented in Table 1.
Women, elderly, and individuals with primary education
were overrepresented in the excluded subjects (Additional
file 1).
Definition of disability
Disability was defined in terms of self-reported difficulties
in performing activities of daily living (ADL)–ability to
transfer in-and-out of bed, transfer in-and-out of chair,
dressing/undressing, washing hands and face, feeding, and
using the toilet – and limitations on mobility. These ques-
tions were part of the recommended instrument to meas-
ure disability proposed by the World Health Organization
[18]. The disability definition used in this study was based
on the availability of the disability questions in the four
HIS. An individual was considered disabled if he/she
reported having difficulties in performing at least one of the
ADLs on his/her own or only being able to perform it with
personal assistance. An individual was also considered
disabled if he/she reported an ability to walk without stop-
ping that was less than 200 meters.
Definition of chronic diseases
The HIS participants were asked about the presence of
disease over the year preceding the interview. In total, 20
diseases or diseases groups were included, based on their
Table 1 Characteristics of the study population, Belgium, 1997, 2001, 2004, and 2008
Characteristics Men Women
15-54 55-64 65-79 ≥80 15-54 55-64 65-79 ≥80
N %* N %* N %* N %* N %* N %* N %* N %*
Survey year
1997 2735 24.4 450 20.3 541 21.3 108 10.3 2698 23.9 482 21.1 693 22.3 221 10.3
2001 3093 27.5 581 26.2 675 26.6 152 14.5 3031 26.9 598 26.2 826 26.6 227 10.6
2004 2848 25.4 585 26.4 811 32.0 385 36.6 2959 26.2 603 26.4 961 31.0 844 39.4
2008 2551 22.7 603 27.2 510 20.1 406 38.6 2590 23.0 597 26.2 624 20.1 849 39.7
Education level
Tertiary 3895 34.7 772 34.8 693 27.3 266 25.3 4486 39.8 657 28.8 591 19.0 259 12.1
Secondary 4799 42.7 934 42.1 967 38.1 360 34.3 4134 36.7 1014 44.5 1213 39.1 736 34.4
Primary 732 6.5 435 19.6 756 29.8 357 34.0 770 6.8 511 22.4 1127 36.3 921 43.0
No diploma 72 0.6 37 1.7 54 2.1 27 2.6 106 0.9 41 1.8 85 2.7 92 4.3
No information 1729 15.4 41 1.8 67 2.6 41 3.9 1782 15.8 57 2.5 88 2.8 133 6.2
Disabled 415 3.7 249 11.2 631 24.9 527 50.1 534 4.7 326 14.3 1003 32.3 1453 67.9
Total 11227 2219 2537 1051 11278 2280 3104 2141
*Not weighted.
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diseases (asthma, chronic bronchitis, and chronic pulmon-
ary diseases), diabetes, cancer, depression, chronic cystitis,
heart attack, stroke, arthritis (rheumatoid arthritis and
osteoarthritis), back pain, osteoporosis, stomach ulcer,
bowel diseases, cirrhosis, gall-stones, cataract, glaucoma,
migraine, thyroid problems, skin diseases, and neuro-
logical diseases (epilepsy and Parkinson’s disease). Other
diseases and conditions, such as injuries and dementia,
were not included in the analysis due to the lack of
information in the four HIS.Statistical analysis
The attribution method was used to estimate the disabil-
ity prevalence by cause, i.e. to attribute disability to dis-
ease and “background”, using cross-sectional data [10].
Analogous to the underlying cause of death, in which
one disease is assigned as underlying cause of death ac-
cording to the death certificate, we aim to attribute each
disability case reported in the surveys to a single cause,
taking into account that individuals can have more than
one disease (comorbidity) and that disability can be
present in individuals without any disease [4].
Even if an individual reports a disease in the survey, this
is not necessarily the cause of the disability. This disability
that is not associated with the diseases included in the ana-
lysis is labelled “background”. Disability in individuals who
did not report any disease is entirely attributed to back-
ground, while disability in individuals who reported diseases
is partitioned among the diseases and background [4].
The method assumes that (i) the distribution of disability
by cause is entirely explained by diseases that are stillpresent at the time of the survey and the background, (ii)
the cause-specific disability rates for each disease were pro-
portionally equal in the time preceding the survey, (iii) indi-
viduals from the same age groups are exposed to the same
background rate, (iv) the causes of disability (diseases and
background) act as independent competing causes, and (v)
the start of the time at risk for disability is the same for all
causes [4].
In the multiple decrement life table, under the assump-
tion of independence between causes of death, an exponen-
tial transformation is applied to the cumulative force of
mortality to obtain the cause-specific probability of death in
the presence of competing risks [19-21]. Analogous to this
method, we used hazards rates to obtain the probability of
being disabled by cause. Under the additive assumption of
the rates, the total disability rate can be obtained by adding
up the cause-specific disability rates [21].
The attribution method is based on the multiple addi-
tive regression model [10] as shown in equation (1).
Y i ¼ Bernoulli πið Þ
πi ¼ 1−e−ηi
ηi ¼ αa þ
Xm
d¼1
βcdXdi
ð1Þ
Where:
 Yi is the binary response (disability) variable for each
individual i;
 πi is the estimated probability that individual i is
disabled;
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 ηi is the total disability rate (linear predictor) for
each individual i;
 αa is the background disability rate by age group a
(1, …, n) (15–54, 55–59, 60–64, 65–69, 70–74,
75–79, ≥ 80 years);
 βcd is the disease-specific disability rate (disabling
impact). It is defined as the product βcd = γc * δd,
where γc is the age pattern, which allows the disease
prevalence to vary across age group c(1, …, k)
(15–54, 55–64, 65–79, and ≥ 80 years), and δd is the
disease effect, specific for each disease d(1, …, m);
 Xdi is the indicator variable for each disease d and
individual i.
Model (1) is a reduced rank regression with one rank
[22], as the number of parameters estimated for the
interaction between age and disease is reduced by as-
suming that the age pattern (γc) varies across age groups
but is similar across diseases and that the disease effect
(δd) differs across diseases, but not by age group. In
other words, instead of estimating m * k (20 * 4 = 80) pa-
rameters, which represents the maximum number of
two-way interaction terms between age and disease, we
only estimate m + k (20 + 4 = 24).
The estimation of the disability prevalence by cause
depends on the prevalence of the disease (Xdi) and the
disabling impact of the disease across age group (βcd)
[11]. The disabling impact represents the rate at which
each chronic disease causes disability among the dis-
eased individuals [23]. The attribution of disability to
background and to disease d is defined in equation (2).
Bi ¼ αa
ηi
 πi
Ddi ¼ βcd Xdi
ηi
 πi
ð2Þ
Where Bi is the probability of individual i to be dis-
abled due to background and Ddi is the probability of in-
dividual i to be disabled due to disease d.
The total number of disabled individuals by back-
ground and by each disease can be obtained as shown in
equation (3).
Nb ¼
XN
i¼1
Bi
Nd ¼
XN
i¼1
Ddi
ð3Þ
Where Nb is the total number of disabled individuals
due to background and Nd is the total number of dis-
abled individuals due to disease d.Finally, the prevalence of disability by cause can be
calculated as shown in equation (4).
Pb ¼ NbN
Pd ¼ NdN
ð4Þ
Where Pb is the prevalence of disabled individuals due
to background, Pd is the prevalence of disabled individ-
uals due to disease d, and N is the total number of
individuals.
Separate models for men and women were fit and the
confidence intervals for the disease prevalence, param-
eter estimates of the models (background disability rates
and disease-specific disability rates), and the prevalence
of disability by cause were estimated by the 2.5th and
97.5th empirical percentiles from 1000 bootstrap replicas
sampled with replacement of equal sample size as the
original data [24].
The diseases that were not significant in the additive
hazards model were included in the “other” diseases
group: chronic cystitis, stomach ulcer, bowel diseases,
cirrhosis, gall-stones, cataract, glaucoma, migraine, thy-
roid problems, and skin diseases.
The statistical analysis was conducted in R, version
3.0.3 [25], using the software developed by Nusselder
and Looman [4,13] to fit the additive regression model
and to estimate the disability prevalence by cause. The
Nelder-Mead simplex optimization technique was used
[26]. Further details about the attribution method and
software are described elsewhere [4,10,13].
Results
Detailed information on the study participants are pre-
sented in Table 1. There was an oversampling of elderly
individuals aged 65 years or older for both men and
women in the 2004 and 2008 HIS. More than one third
of elderly subjects reported low level of education (no
diploma or primary school). The proportion of disabled
individuals increased with age: more than half the indi-
viduals aged 80 years or older were disabled. Disability
was higher among women compared to men in all age
groups. It is important to notice that young individuals
(15–54 years) already reported disability, although the
proportion of disabled individuals in this age group was
low (less than 5%) (Table 1).
Among men aged 15 to 79 years, arthritis, other dis-
eases, back pain, and chronic respiratory diseases were
the most prevalent diseases. In the oldest old men
(≥80 years), arthritis, other diseases, heart attack and
chronic respiratory diseases were the most prevalent dis-
eases (Table 2). A low prevalence was observed for
neurological diseases, stroke, and osteoporosis. For all
Table 2 Disease prevalence and disease-specific disability rates (disabling impacts), Belgium, 1997, 2001, 2004, and 2008
Diseases Disease prevalence Disabling Impact
15-54 years 55-64 years 65-79 years ≥80 years 15-54 years 55-64 years 65-79 years ≥80 years
% 95% CI % 95% CI % 95% CI % 95% CI Rate 95% CI Rate 95% CI Rate 95% CI Rate 95% CI
Men
Chronic respiratory diseases 5.2 4.7; 5.7 9.7 8.1; 11.4 16.5 14.4; 18.5 20.9 17.0; 24.9 0.06 0.03; 0.08 0.12 0.07; 0.19 0.14 0.08; 0.22 0.25 0.09; 0.40
Diabetes 1.2 1.0; 1.4 6.8 5.4; 8.2 10.7 9.2; 12.3 10.4 7.5; 13.6 0.03 0.01; 0.06 0.06 0.01; 0.12 0.07 0.02; 0.14 0.12 0.03; 0.22
Cancer 0.3 0.2; 0.5 1.9 1.3; 2.6 4.7 3.5; 6.0 4.7 3.0; 6.5 0.07 0.02; 0.14 0.15 0.04; 0.30 0.18 0.05; 0.34 0.31 0.07; 0.58
Depression 4.3 3.8; 4.8 4.8 3.8; 5.8 5.3 3.7; 7.3 4.5 2.7; 6.6 0.07 0.03; 0.10 0.14 0.07; 0.24 0.17 0.08; 0.30 0.29 0.10; 0.50
Neurological diseases 0.7 0.5; 0.9 0.7 0.3; 1.1 2.0 1.1; 3.2 3.6 2.0; 5.6 0.30 0.17; 0.46 0.62 0.37; 1.03 0.74 0.43; 1.19 1.31 0.46; 2.00
Cardiovascular diseases
Heart attack 1.1 0.9; 1.4 8.6 6.9; 10.3 14.7 12.9; 16.7 21.6 17.6; 25.4 0.09 0.05; 0.13 0.18 0.11; 0.28 0.21 0.14; 0.31 0.38 0.15; 0.54
Stroke 0.2 0.1; 0.3 1.0 0.6; 1.5 2.0 1.4; 2.8 5.6 3.2; 8.3 0.14 0.06; 0.26 0.31 0.14; 0.58 0.36 0.16; 0.66 0.64 0.22; 1.02
Musculoskeletal diseases
Back pain 11.1 10.4; 11.9 16.9 14.8; 19.2 18.0 15.6; 20.6 13.3 10.6; 16.3 0.06 0.04; 0.08 0.13 0.08; 0.19 0.15 0.10; 0.22 0.27 0.10; 0.37
Osteoporosis 0.4 0.3; 06 1.7 1.1; 2.4 3.7 2.7; 4.8 5.7 3.7; 8.2 0.16 0.08; 0.29 0.34 0.19; 0.59 0.41 0.22; 0.71 0.72 0.30; 1.09
Arthritis 6.9 6.2; 7.5 22.8 20.4; 25.2 29.2 26.5; 31.8 34.5 30.1; 38.8 0.04 0.02; 0.06 0.09 0.05; 0.12 0.10 0.06; 0.15 0.18 0.06; 0.27
“Other” diseases 13.8 13.0; 14.7 19.1 16.9; 21.3 25.6 23.1; 28.0 33.5 29.3; 38.1 0.02 0.01; 0.03 0.04 0.01; 0.07 0.05 0.01; 0.09 0.08 0.02; 0.15
Women
Chronic respiratory diseases 6.6 6.0; 7.3 8.3 7.0; 9.5 12.6 10.9; 14.3 11.3 8.8; 14.1 0.06 0.03; 0.08 0.09 0.05; 0.15 0.14 0.08; 0.21 0.26 0.14; 0.41
Diabetes 1.4 1.1; 1.7 6.0 4.8; 7.3 9.9 8.5; 11.3 8.6 7.0; 10.5 0.07 0.03; 0.12 0.12 0.06; 0.19 0.17 0.08; 0.27 0.32 0.14; 0.53
Cancer 0.8 0.6; 1.0 2.7 1.9; 3.6 4.5 3.2; 5.9 3.7 1.9; 6.3 0.08 0.02; 0.15 0.13 0.04; 0.24 0.19 0.06; 0.34 0.36 0.10; 0.69
Depression 6.7 6.1; 7.3 9.6 8.1; 11.2 9.5 8.1; 11.0 7.5 5.8; 9.7 0.06 0.03; 0.09 0.10 0.05; 0.16 0.14 0.07; 0.23 0.27 0.12; 0.45
Neurological diseases 0.7 0.5; 1.0 1.5 0.9; 2.2 1.7 1.2; 2.3 3.6 2.2; 5.2 0.22 0.11; 0.38 0.38 0.18; 0.63 0.55 0.26; 0.89 1.02 0.49; 1.73
Cardiovascular diseases
Heart attack 0.9 0.6; 1.1 3.7 2.7; 4.9 9.7 8.2; 11.4 13.9 10.9; 17.5 0.08 0.04; 0.13 0.13 0.06; 0.21 0.18 0.09; 0.31 0.35 0.16; 0.58
Stroke 0.2 0.1; 0.4 1.2 0.6; 1.9 2.3 1.6; 3.2 5.0 3.3; 7.2 0.28 0.14; 0.48 0.48 0.25; 0.80 0.69 0.36; 1.13 1.29 0.65; 2.15
Musculoskeletal diseases
Back pain 10.9 10.1; 11.7 20.4 18.2; 22.7 25.2 22.8; 27.5 21.4 18.4; 24.4 0.07 0.05; 0.09 0.12 0.07; 0.17 0.17 0.11; 0.23 0.32 0.19; 0.47
Osteoporosis 1.6 1.3; 1.9 11.2 9.6; 12.9 20.1 18.2; 22.2 22.1 19.1; 25.4 0.03 0.01; 0.06 0.05 0.01; 0.10 0.07 0.02; 0.14 0.14 0.03; 0.28
Arthritis 8.8 8.1; 9.5 32.8 30.3; 36.3 50.2 47.7; 52.6 55.0 51.0; 59.0 0.09 0.06; 0.12 0.15 0.11; 0.19 0.22 0.11; 0.20 0.41 0.27; 0.55
“Other” diseases 26.8 25.7; 27.9 33.5 30.9; 36.3 41.1 38.5; 43.7 44.2 40.4; 47.8 0.01 0.00; 0.02 0.02 0.00; 0.04 0.03 0.00; 0.04 0.05 0.01; 0.10
“Other” diseases included: chronic cystitis, stomach ulcer, bowel diseases, cirrhosis, gall-stones, cataract, glaucoma, migraine, thyroid problems, and skin diseases.
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cept for depression (Table 2).
Among women, arthritis, other diseases, back pain and
depression were the most prevalent diseases in young
women (15–64 years), while the three musculoskeletal
diseases (arthritis, back pain, and osteoporosis) and
other diseases were by far the most prevalent diseases in
elderly women (≥65 years). Neurological diseases, stroke,
and cancer were the least prevalent diseases among
women (Table 2).
Higher prevalence of chronic respiratory diseases, can-
cer, depression, osteoporosis, arthritis, and other diseases
was observed for women compared to men aged 15 to
54 years. For individuals aged 55–64 years, the preva-
lence of previous heart attack in men was more than
twice as large as the prevalence in women. However, de-
pression, arthritis, osteoporosis, and other diseases were
more prevalent among women. In the older individuals
(≥65 years), chronic respiratory diseases and heart attack
were more prevalent in men. Nonetheless, musculoskel-
etal and other diseases were more prevalent in elderly
women compared to elderly men (Table 2).
Low background disability rates were observed in
young individuals (<65 years), with an increasing trend
over age. Although not significant, a small gender gap
was observed, where higher point estimates for the back-
ground disability rates were observed among women
(Figure 1).
The highest disabling impacts were observed for
neurological diseases and stroke for men and women.
Osteoporosis was also important for men while arthritis
was among the most disabling diseases for women. Low
disabling impacts were observed for other diseases, dia-
betes, and arthritis among men, and for other diseases,
osteoporosis, and chronic respiratory diseases among
women. Overall, an increase in disabling impacts with
increasing age was observed. Men showed higher0.
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Figure 1 Background disability rate by gender and age group.
Health Interview Survey, Belgium, 1997, 2001, 2004, and 2008.disabling impacts than women across all age groups for
osteoporosis (Table 2).
The disability prevalence was low among young indi-
viduals (<5%) and it increased over age. A higher preva-
lence of disability was observed in women compared to
men for all age groups, except for individuals aged 55 to
64 years (Table 3).
The attribution of disability to diseases depends on the
disease prevalence and the disability rate of each disease.
The far highest contributors to the burden of disability
were musculoskeletal diseases, followed by cardiovascu-
lar diseases for men and women (Table 3, Figure 2). For
all ages, musculoskeletal diseases accounted for 15 to
36% of the prevalence of disability in men and 31 to 56%
in women. Cardiovascular diseases represented 13 to
14% of the disability burden in men aged 55 years or
older and 7% in women aged 55 years or older. While
depression was also an important cause of disability in
young individuals (15–54 years), representing 7% of the
disability burden, chronic respiratory diseases accounted
for 7% of the disability prevalence in the youngest and 2
to 6% in the oldest-old subjects (Figure 2).
Among elderly individuals (≥65 years), the three main
contributors to the disability burden – musculoskeletal,
cardiovascular, and chronic respiratory diseases – repre-
sented 34 to 44% and 49 to 65% of the disability preva-
lence in men and women, respectively (Figure 2). It is
important to notice that the contribution of musculo-
skeletal diseases was much larger than cardiovascular
diseases for both men and women (Figure 2).
In men, back pain was the most important contributor
of the musculoskeletal group among young individuals
(<65 years) while arthritis was the most important con-
tributor among the oldest men (≥65 years). In women,
arthritis was the main contributor of the musculoskeletal
group in all age groups. For cardiovascular diseases,
heart attack was the main cause of disability in both
men and women (Table 3).
Cancer and neurological diseases showed a low contri-
bution to the prevalence of disability, accounting for less
than 5% of the total disability. Furthermore, depression
also had a low contribution to the prevalence of disabil-
ity among elderly women and men (<3%) (Figure 2).
A large relative contribution of background was ob-
served, especially among the youngest men (43%) and
women (39%) and among the oldest old, in which more
than 50% of the total disability prevalence was attributed
to background (Figure 2).
A model without the interaction between diseases and
disability, which provides the estimates for the total
population of 15 years and older, was also fitted and in-
cluded as an additional file (Additional file 2). By ignor-
ing the interaction of age and diseases, back pain, heart
attack, and arthritis were the main contributors to the
Table 3 Absolute contribution of diseases to the prevalence of disability (per 100), Belgium, 1997, 2001, 2004, and 2008
Diseases Age group (years)
15-54 55-64 65-79 ≥80
Prevalence 95% CI Prevalence 95% CI Prevalence 95% CI Prevalence 95% CI
Men
Background 1.55 1.55; 1.56 2.60 2.55; 2.66 9.67 9.37; 9.98 25.74 24.02; 27.59
Chronic respiratory diseases 0.28 0.16; 0.40 1.03 0.54; 1.59 1.92 1.02; 2.86 2.96 1.26; 5.02
Diabetes 0.03 0.01; 0.06 0.37 0.10; 0.70 0.64 0.16; 1.21 0.74 0.19; 1.57
Cancer 0.02 0.00; 0.05 0.25 0.06; 0.49 0.66 0.18; 1.21 0.79 0.21; 1.61
Depression 0.27 0.13; 0.42 0.58 0.27; 0.93 0.67 0.32; 1.16 0.67 0.27; 1.22
Neurological diseases 0.18 0.10; 0.29 0.30 0.13; 0.52 0.97 0.44; 1.73 1.80 0.72; 3.22
Cardiovascular diseases
Heart attack 0.09 0.05; 0.15 1.32 0.76; 2.00 2.51 1.58; 3.53 4.37 2.26; 6.82
Stroke 0.03 0.01; 0.05 0.25 0.08; 0.50 0.54 0.25; 0.84 1.82 0.67; 3.44
Musculoskeletal diseases
Back pain 0.63 0.44; 0.83 1.91 1.17; 2.72 2.18 1.51; 2.91 1.89 0.95; 2.98
Osteoporosis 0.07 0.03; 0.12 0.47 0.26; 0.71 1.09 0.54; 1.74 1.93 0.95; 3.22
Arthritis 0.26 0.15; 0.38 1.73 1.11; 2.48 2.42 1.39; 3.51 3.50 1.58; 5.86
“Other” diseases 0.24 0.08; 0.42 0.65 0.23; 1.17 0.95 0.30; 1.71 1.50 0.44; 3.02
Total disability prevalence 3.65 3.26; 4.02 11.45 9.51; 13.43 24.21 21.59; 26.71 47.71 40.23; 54.38
Women
Background 1.81 1.81; 1.82 3.80 3.74; 3.85 12.02 11.64; 12.38 36.80 34.75; 39.01
Chronic respiratory diseases 0.34 0.21; 0.50 0.66 0.37; 1.01 1.26 0.71; 1.96 1.43 0.78; 2.29
Diabetes 0.09 0.04; 0.16 0.59 0.29; 0.98 1.23 0.62; 1.98 1.40 0.66; 2.25
Cancer 0.06 0.02; 0.11 0.30 0.08; 0.58 0.63 0.21; 1.11 0.68 0.16; 1.56
Depression 0.35 0.19; 0.54 0.78 0.37; 1.29 0.97 0.48; 1.56 0.99 0.45; 1.69
Neurological diseases 0.15 0.06; 0.27 0.39 0.19; 0.66 0.55 0.27; 0.88 1.32 0.65; 2.17
Cardiovascular diseases
Heart attack 0.06 0.03; 0.10 0.38 0.17; 0.64 1.27 0.68; 2.05 2.33 1.07; 3.75
Stroke 0.06 0.02; 0.13 0.40 0.20; 0.66 0.89 0.48; 1.44 2.29 1.27; 3.54
Musculoskeletal diseases
Back pain 0.70 0.48; 0.93 2.00 1.26; 2.93 3.13 2.07; 4.27 3.49 2.22; 4.83
Osteoporosis 0.05 0.01; 0.09 0.50 0.13; 0.92 1.15 0.30; 2.13 1.61 0.41; 2.99
Arthritis 0.72 0.50; 0.99 4.20 3.15; 5.52 8.29 6.41; 10.26 12.02 8.63; 15.46
“Other” diseases 0.30 0.07; 0.53 0.58 0.13; 1.07 0.91 0.20; 1.71 1.32 0.28; 2.53
Total disability prevalence 4.68 4.18; 5.22 14.58 12.76; 16.79 32.30 29.57; 34.88 65.68 61.47; 69.41
The disease contribution do not sum to the total disability prevalence due to rounding.
“Other” diseases included: chronic cystitis, stomach ulcer, bowel diseases, cirrhosis, gall-stones, cataract, glaucoma, migraine, thyroid problems, and skin diseases.
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chronic respiratory diseases were the most important
contributors among women (Additional file 2).
Discussion
The major contributors to the disability burden in
Belgium were musculoskeletal diseases, followed by car-
diovascular and chronic respiratory diseases.Among elderly (≥65 years) individuals, musculoskeletal
diseases were the main cause of disability due to their
high prevalence and moderate disabling impact, while
cardiovascular diseases were also an important cause of
disability because of their moderate prevalence and high
disabling impact. Furthermore, chronic respiratory dis-
eases were among the main causes of disability due to
the combination of their moderate prevalence and
Proportion of total disability (%)
Background
Other
Neurological
Cancer
Diabetes
Depression
CRD
CVD
Musculoskeletal
0 10 20 30 40 50 60
65−79 years 80+ years
Background
Other
Neurological
Cancer
Diabetes
Depression
CRD
CVD
Musculoskeletal
15−54 years
0 10 20 30 40 50 60
55−64 years
Women Men
Figure 2 Relative contribution of diseases to the prevalence of disability. Health Interview Survey, Belgium, 1997, 2001, 2004, and 2008.
Legend: Contributions expressed as the proportion of total disability (the sum of the cause-specific contribution across age group and gender
sum to 100%). CVD – cardiovascular diseases: stroke and heart attack; CRD – chronic respiratory diseases; Musculoskeletal diseases: back pain,
osteoporosis, and arthritis (rheumatoid arthritis and osteoarthritis); Neurological diseases: epilepsy and Parkinson’s disease; other diseases:
chronic cystitis, stomach ulcer, bowel diseases, cirrhosis, gall-stones, cataract, glaucoma, migraine, thyroid problems, and skin diseases.
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the disability burden depends on both the prevalence
and disabling impact of the diseases [4,11]. Nonetheless,
neurological diseases, which are known strong disabling
diseases [14,27], presented a high disabling impact but a
low prevalence, resulting in a low contribution of the
disability burden in Belgium. This low contribution can
also be related to the fact that dementia and Alzheimer
disease, important contributors to the disability burden
in the elderly, were not included in this disease group
due to lack of availability in the four HIS.
The occurrence of disability in the youngest individ-
uals (15–54 years) indicates that attention should also be
given to this group, although young adults are often per-
ceived as “healthy”. More important, depression was
identified as one of the main causes of disability in
young individuals. Other studies already showed that de-
pression is one of the most disabling diseases related to
loss of quality of life among the mental disorders [27],which can also affect the performance of ADLs [28,29].
Unipolar depressive disorders were the main cause of
years lost due to disability in the population of 15 to
24 years of age worldwide [30]. Our findings highlight
the importance of including this disease in the surveys
and in the analysis of cause-specific disability.
A large contribution of background to the disability
burden may reflect that: (i) disability can occur without
any disease, (ii) diseases in the survey can be underre-
ported, (iii) diseases and conditions may no longer be
present in the year preceding the interview (e.g., conse-
quences of accidents), (iv) the causes of disability (dis-
eases or conditions) were not included in the analysis
[11], or (v) diseases may be underdiagnosed. The relative
background contribution was larger in the youngest and
oldest age groups, which might indicate that the main
causes of disability in these groups were not included in
the list of chronic diseases explored during the surveys,
e.g. permanent consequences of accidents and injuries in
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oldest individuals [10,13]. Aging-related functional loss
may also explain the large background contribution ob-
served among elderly [4,10].
The comparability of our results with previous studies
that also used the attribution method [3,10,11,13-15] is
limited mainly due to differences in the disability defin-
ition, the diseases included in the analysis, the target
population, and the survey methodology.
In the present study, disability was defined based on
six ADL functions and mobility limitations, including
moderate and severe disability levels. The use of this def-
inition is supported by the fact that ADLs are considered
basic tasks to survival. Hence, difficulties in performing
these activities suggests serious health problems [31].
The first study that used the attribution method, ana-
lysed the data of the 1997 Belgian HIS. In this study, dis-
ability was defined based on four moderate or severe
functional limitations from the short-form 36 and in-
cluded only individuals age 30 years and older [13].
Other three studies used Dutch data and included only
severely disabled individuals. While in the first study
[10] data from 1990 to 1994 surveys were analysed and
the disability indicator was based on ADL, communica-
tion and sensorial limitations, the two most recent stud-
ies used pooled data from 2001 to 2007. In these two
studies, two different disability definitions were used: (i)
based on ADL and mobility limitations [11], which is
the most comparable with the present study, and (ii)
based on hearing, vision, and mobility limitations [3].
The study conducted in Germany [14] defined disability
based on the health assessment questionnaire disability
index, which also includes ADL limitations, and was re-
stricted to individuals aged 65 years or older. In contrast
to previous studies, the study conducted in China [15]
focused on the causes of impairments, such as intellec-
tual deficits, hearing and vision limitations and not on
the causes of ADL limitations. Thus, we did not include
the results of the Chinese study in the comparison.
We did not compare our results with the Global Bur-
den of Diseases study (GBD 2010) [32], also due to
methodological differences. In the GBD 2010, the dis-
ability burden was assessed by the population health
metric called years lived with disability (YLD), which is a
function of the prevalence of disease sequelae and dis-
ability weights [32]. The disability weights were used to
quantify the severity of disease sequelae and were based
on survey responses of the general population [32]. In
contrast, the attribution method used in this study esti-
mates the disability prevalence by cause as a function of
the disease prevalence and the disease-specific disability
rates. The disease-specific disability rates are estimated
from the additive regression model. Another difference
between the two methods is the outcome of interest:while the GBD 2010 focused on years lived with disabil-
ity, which can be considered a measure of healthiness of
years lived with a disease [32], the attribution method
estimates the disability burden based on the disability
prevalence by cause, where disability was defined based
on functional and mobility limitations.
Despite the methodological differences, musculoskeletal
and cardiovascular diseases were among the main causes
of disability in all previous studies [3,10,11,13-15,32,33].
There are several limitations in the present study that
should be considered when interpreting the results.
Temporal bias might have occurred as a consequence of
the use of cross-sectional data and disability may be in-
correctly attributed to disease when disability onset pre-
ceded disease onset [11]. Although selection bias can
occur due to high non-response rates, it may be reduced
with the use of post-stratification weights under the
assumption that non-responders are not different from
responders with similar demographic characteristics
[11,34]. Also, lack of information of possible important
causes of disability such as dementia and injuries, the
use of self-reported diseases, and underdiagnoses of dis-
ease may have resulted in an overestimation of the back-
ground contribution. The validity of self-reported
diseases is specific for each disease [35]: while a good
validity was previously reported for diabetes, hyperten-
sion, stroke [36], cancer [37], and asthma [38], a poor
validity was observed for self-reported thyroid problems
[39] and arthritis [40]. Additionally, previous studies
showed a moderate to weak relationship between self-
reported and performed-based ADL [41] and mobility
limitations [42] in the elderly. One possible explanation
for these differences is that performance-based measures
often do not reflect adaptations made to living situations
of a person [41]. Moreover, our disability definition was
restricted to functional and mobility limitations. Although
other measures of disability, such as instrumental activities
of daily living, cognitive impairments, and sensory limita-
tions can also be important in the disablement process
[43], we did not include them because they were not con-
sistently available in the four Belgian HIS.
The use of a large age interval for the young individ-
uals (15–54 years) assumes that the disease-specific rates
and respective contributions were constant in this age
group. Although the disease-specific rates tended to in-
crease with age, a model with smaller age intervals
(5 years) was initially fitted (data not shown). However,
the disabling impacts were very small and similar for in-
dividuals younger than 55 years. Therefore, this larger
age group was used in order to have a more parsimoni-
ous model.
Recently, a modification of the average attribution frac-
tion has been proposed to account for the coexistence of
diseases in the mortality analysis [44,45]. The attribution
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more than one disease by including interaction
terms between diseases as the Xdi variable in the
model [4]. However, no interaction terms between
diseases were included in our analysis due to the
large number of diseases and the large sample size,
which would result in a computationally intensive
task. By ignoring the interaction of diseases, it is
possible that both under and overestimation of the
attribution of disability to diseases occurred, similar
to what has been shown in the mortality analysis
[44,45].
Furthermore, the exclusion of individuals for whom
disease or disability were missing suggests that the preva-
lence of disability might be underestimated, as most of
these individuals were women, elderly, and low educated,
who are known to have high disability prevalence [13,46].
However, since this proportion was small (8%), the impact
on the disability prevalence may not be important. In
addition, one could argue that the use of pooled data from
the four HIS may have biased the results due to changes
in the disability prevalence over the 1997 to 2008 period.
Nevertheless, as shown in Additional file 3, the disability
prevalence seemed to be stable across gender and age
groups over the period. The use of pooled data allowed in-
creasing the power of the statistical analysis, especially in
the older age groups.
An important strength of this study is that the attribu-
tion method applied here takes into account that subjects
without reported diseases can be disabled (“background”).
Additionally, the additive property of rates (background
and disease-specific disability rates) allows partitioning the
disability prevalence into additive disease contributions in
the presence of comorbidity [10].
Added values of this study include the analysis of de-
pression, which showed to be one of the major causes of
disability in young individuals and the inclusion of insti-
tutionalized population in the survey sample, allowing a
better generalization of the results to the Belgian elderly
population.Conclusions
In summary, this study identified musculoskeletal, car-
diovascular, and respiratory diseases as the main causes
of disability in Belgium across all age groups in both
men and women. Besides these conditions, depression
was also an important cause of disability, especially
among young individuals. Intervention policies should
focus on the prevention of disease onset and reduction
of disabling impacts of these diseases.
It would be interesting to investigate whether the
model can be extended to incorporate a multinomial
response (disability level), allowing the comparison ofdisability prevalence by cause according to severity
level (e.g., moderate and severe).
Further research should explore the role of risk factors
for chronic diseases, such as smoking and obesity, in the
cause-specific disability prevalence.
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